The solutions will combine human milk oligosaccharides (HMOs) from dsm-firmenich and probiotics from Lallemand Health Solutions with the aim to make the composition of infant formula closer to breast milk.
Sirio Pharma is delivering immune supporting postbiotics in an approachable gummy format while Kerry is offering multiple benefits via its Plenibiotics postbiotic ingredient.